AC
CELG

Allstate Corporation’s Celgene Corp CELG Stock Holding History

Allstate Corporation’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-59,539
Closed -$5.91M – 664
2019
Q3 		$5.91M Sell
59,539
-1,942
-3% -$185K 0.1% 102
2019
Q2 		$5.68M Buy
61,481
+14,711
+31% +$1.4M 0.1% 108
2019
Q1 		$4.41M Buy
46,770
+33,922
+264% +$2.97M 0.12% 122
2018
Q4 		$823K Buy
+12,848
New +$948K 0.03% 295
2017
Q3 		– Sell
-18,366
Closed -$2.38M – 295
2017
Q2 		$2.38M Buy
18,366
+1,474
+9% +$181K 0.13% 70
2017
Q1 		$2.1M Sell
16,892
-20,177
-54% -$2.41M 0.13% 120
2016
Q4 		$4.29M Sell
37,069
-30,545
-45% -$3.4M 0.26% 119
2016
Q3 		$7.07M Buy
+67,614
New +$7.32M 0.5% 28
2014
Q3 		– Sell
-114,000
Closed -$9.79M – 273
2014
Q2 		$9.79M Hold
114,000
– – 0.26% 125
2014
Q1 		$7.96M Buy
+114,000
New +$9.03M 0.26% 122

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Allstate Corporation's CELG Position: Q4 2019 in Review

Allstate Corporation sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 59,539 shares — an estimated $5.91M sold.

Allstate Corporation first reported a position in CELG in Q1 2014 and held it in 10 quarters. The position peaked at $9.79M in Q2 2014. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Allstate Corporation reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Allstate Corporation sold 59,539 Celgene Corp shares in Q4 2019, an estimated $5.91M.
  • Allstate Corporation first reported a position in Celgene Corp in Q1 2014 and held it in 10 quarters.
  • Allstate Corporation's Celgene Corp position peaked at $9.79M in Q2 2014.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Allstate Corporation's 13F filing for Q4 2019, filed 14 Feb 2020.